Table 1 Demographic and clinical characteristics of study participants. Mean ± SD values are represented in the table
Group | Migraineurs with (n = 3) and without aura (n = 21) | Healthy control subjects (n = 13) |
|---|---|---|
Gender | female n = 23 male n = 1 | female n = 13 |
Age (years) | 35 ± 12.25 | 35 ± 4.96 |
Body mass index (BMI) | 22.21 ± 4.57 | 24 ± 3.47 |
Last meal (hours ago) | 6.59 ± 6.29 | 3.69 ± 5.32 |
Co-morbidities and drugs of migraine patients | ||
 Known other diseases | yes n = 10 no n = 14 |  |
 Regular medication (except for attack therapy) | yes n = 7 no n = 17 |  |
 Hormonal contraceptives | yes n = 8 no n = 16 |  |
 Antimigraine prophylactic therapy | no n = 24 |  |
Clinical features of the headache | ||
 Disease duration (years) | 15 ± 12 |  |
 Attack frequency (attack/year) | 32 ± 37.37 |  |
 Visual analogue scale (VAS) | 7 ± 1.44 |  |
 Allodynia | yes n = 9 no n = 15 |  |
 Chronic pain | yes n = 3 no n = 21 |  |
 Menstruation-headache relationship | sensitive n = 10 independent n = 13 |  |
 Migraineurs in the family | yes n = 15 no n = 9 |  |
 Regular sport activity | yes n = 13 no n = 11 |  |
Features of attacks before samplings | ||
 Number of attacks in the previous month | 3 ± 3.31 |  |
 Last attack before interictal blood sampling (days ago) | 16.58 ± 28.35 |  |
 Beginning of attack before ictal blood sampling (hours) | 17.91 ± 29.47 |  |